Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort

[1]  F. Nosten,et al.  Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort , 2015, Malaria Journal.

[2]  E. Ashley,et al.  The duration of Plasmodium falciparum infections , 2014, Malaria Journal.

[3]  E. Ashley,et al.  Primaquine: the risks and the benefits , 2014, Malaria Journal.

[4]  R. Price,et al.  Effect of Early Detection and Treatment on Malaria Related Maternal Mortality on the North-Western Border of Thailand 1986–2010 , 2012, PloS one.

[5]  F. Nosten,et al.  Randomized, Double-Blind, Placebo-Controlled Trial of Monthly versus Bimonthly Dihydroartemisinin-Piperaquine Chemoprevention in Adults at High Risk of Malaria , 2012, Antimicrobial Agents and Chemotherapy.

[6]  J. Simpson,et al.  Estimation of gestational age from fundal height: a solution for resource-poor settings , 2011, Journal of The Royal Society Interface.

[7]  M. Gatton,et al.  Artemisinin‐induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure. , 2010, The Journal of infectious diseases.

[8]  A. Papageorghiou,et al.  Obstetric ultrasound scanning by local health workers in a refugee camp on the Thai–Burmese border , 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[9]  C. Menéndez,et al.  Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women , 2009, Malaria Journal.

[10]  F. Nosten,et al.  A Randomised Controlled Trial of Artemether-Lumefantrine Versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy , 2008, PLoS medicine.

[11]  F. Nosten,et al.  Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. , 2008, The American journal of tropical medicine and hygiene.

[12]  F. Nosten,et al.  Artemisinin-based combination treatment of falciparum malaria. , 2007, The American journal of tropical medicine and hygiene.

[13]  S. Meshnick,et al.  A Randomized Controlled Pilot Trial of Azithromycin or Artesunate Added to Sulfadoxine-Pyrimethamine as Treatment for Malaria in Pregnant Women , 2007, PloS one.

[14]  F. Nosten,et al.  In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border , 2007, Malaria Journal.

[15]  F. Nosten,et al.  Case management of malaria in pregnancy. , 2007, The Lancet. Infectious diseases.

[16]  F. Nosten,et al.  Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double‐blind, placebo‐controlled trial , 2007, Tropical medicine & international health : TM & IH.

[17]  F. Nosten,et al.  A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. , 2005, The Journal of infectious diseases.

[18]  A. Björkman,et al.  In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  R. Price,et al.  In Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up , 2004, Antimicrobial Agents and Chemotherapy.

[20]  F. Nosten,et al.  Malaria in pregnancy and the endemicity spectrum: what can we learn? , 2004, Trends in parasitology.

[21]  S. Meshnick,et al.  The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. , 2004, The American journal of tropical medicine and hygiene.

[22]  F. Nosten,et al.  Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  R. Snow,et al.  Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria , 2003 .

[24]  P. Brasseur,et al.  Combination therapy for malaria: the way forward? , 2002, Drugs.

[25]  N. White,et al.  Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[26]  J. M. Rubio,et al.  Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[27]  J. Piva,et al.  [Eyes on the present and looking into the future] , 2001, Jornal de pediatria.

[28]  N. White,et al.  Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[29]  R. Price,et al.  Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  M. Hoshen,et al.  Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of ‘dormancy’, a partial cytostatic effect of the drug, and its implication for treatment regimens , 2000, Parasitology.

[31]  Richard N. Price,et al.  Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study , 2000, The Lancet.

[32]  R. Price,et al.  Genetic analysis of Plasmodium falciparum infections on the north-western border of Thailand. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  F. Nosten,et al.  Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. , 1999, The American journal of tropical medicine and hygiene.

[34]  G. Snounou,et al.  Sampling and storage of blood and the detection of malaria parasites by polymerase chain reaction. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[35]  G. Snounou,et al.  The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. , 1998, Parasitology today.

[36]  N. White,et al.  The epidemiology of severe malaria in an area of low transmission in Thailand. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[37]  S. Nakazawa,et al.  Plasmodium falciparum: recrudescence of parasites in culture. , 1995, Experimental parasitology.

[38]  N. White,et al.  Malaria during pregnancy in an area of unstable endemicity. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[39]  K. Kain,et al.  Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood , 1991, Journal of clinical microbiology.

[40]  B. Haneberg,et al.  CLINICAL ASSESSMENT OF GESTATIONAL AGE IN THE NEWBORN INFANT , 1981, Acta paediatrica Scandinavica.

[41]  G. Covell.  Relationship between malarial parasitaemia and symptoms of the disease: a review of the literature. , 1960, Bulletin of the World Health Organization.

[42]  G. Jeffery,et al.  The duration in the human host of infections with a Panama strain of Plasmodium falciparum. , 1954, The American journal of tropical medicine and hygiene.

[43]  D E EYLES,et al.  The duration of untreated or inadequately treated Plasmodium falciparum infections in the human host. , 1951, Journal. National Malaria Society.